APA

Hancock A. A., Buckner S. A., Giardina W. J., Brune M. E., Lee J. Y., Morse P. A., Oheim K. W., Stanisic D. S., Warner R. B. & Kerkman D. J. (19950414). Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. : The Journal of pharmacology and experimental therapeutics.

Chicago

Hancock A A, Buckner S A, Giardina W J, Brune M E, Lee J Y, Morse P A, Oheim K W, Stanisic D S, Warner R B and Kerkman D J. 19950414. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. : The Journal of pharmacology and experimental therapeutics.

Harvard

Hancock A. A., Buckner S. A., Giardina W. J., Brune M. E., Lee J. Y., Morse P. A., Oheim K. W., Stanisic D. S., Warner R. B. and Kerkman D. J. (19950414). Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. : The Journal of pharmacology and experimental therapeutics.

MLA

Hancock A A, Buckner S A, Giardina W J, Brune M E, Lee J Y, Morse P A, Oheim K W, Stanisic D S, Warner R B and Kerkman D J. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. : The Journal of pharmacology and experimental therapeutics. 19950414.